Acute Schizophrenia Study
Research payments
$17,070,853
Through program year 2023, $17,070,853 in research payments was reported against Acute Schizophrenia Study, across 577 payments.
- Paid by (largest first)
- Hoffmann-La Roche Limited; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $2,670,414 | 143 |
| 2022 | Research | $2,525,393 | 176 |
| 2021 | Research | $11,095,573 | 229 |
| 2020 | Research | $779,474 | 29 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Scott Bartley Dallas, TX Named on 55 payments
- Rishi Kakar North Miami, FL Named on 52 payments
- George Konis Little Rock, AR Named on 21 payments
- Shishuka Malhotra Canton, OH Named on 19 payments
- Robert Riesenberg Atlanta, GA Named on 19 payments
- Marina Bussel Culver City, CA Named on 17 payments
- Grace Morehart Baldwin Park, CA Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.